BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 20299634)

  • 1. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial.
    Müller F; Christ-Crain M; Bregenzer T; Krause M; Zimmerli W; Mueller B; Schuetz P;
    Chest; 2010 Jul; 138(1):121-9. PubMed ID: 20299634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].
    Julián-Jiménez A; Timón Zapata J; Laserna Mendieta EJ; Parejo Miguez R; Flores Chacartegui M; Gallardo Schall P
    Med Clin (Barc); 2014 Apr; 142(7):285-92. PubMed ID: 24120103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?
    Pereira JM; Teixeira-Pinto A; Basílio C; Sousa-Dias C; Mergulhão P; Paiva JA
    J Crit Care; 2013 Dec; 28(6):970-4. PubMed ID: 24216331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin levels in community-acquired pneumonia - correlation with aetiology and severity.
    Johansson N; Kalin M; Backman-Johansson C; Larsson A; Nilsson K; Hedlund J
    Scand J Infect Dis; 2014 Nov; 46(11):787-91. PubMed ID: 25195651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Community-acquired pneumonia and procalcitonin, an opportunity to improve?].
    Tudela P; Mòdol JM
    Med Clin (Barc); 2014 Apr; 142(7):303-5. PubMed ID: 24183120
    [No Abstract]   [Full Text] [Related]  

  • 6. Procalcitonin as a marker of serious bacterial infections in febrile children younger than 3 years old.
    Mahajan P; Grzybowski M; Chen X; Kannikeswaran N; Stanley R; Singal B; Hoyle J; Borgialli D; Duffy E; Kuppermann N
    Acad Emerg Med; 2014 Feb; 21(2):171-9. PubMed ID: 24673673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A; Christ-Crain M; Thomann R; Hoess C; Henzen C; Werner Z; Mueller B; Schuetz P;
    Clin Chem Lab Med; 2015 Mar; 53(4):559-66. PubMed ID: 25014522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M; Yamaki K; Hirasawa N; Yagi T
    Respir Care; 2014 Apr; 59(4):564-73. PubMed ID: 24170911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH; Wee JH; Choi SP; Oh SH
    Am J Emerg Med; 2012 Sep; 30(7):1248-54. PubMed ID: 22030193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of high-mobility group-box 1 protein, lipopolysaccharide-binding protein and procalcitonin in severe community-acquired infections and bacteraemia: a prospective study.
    Gaïni S; Koldkjaer OG; Møller HJ; Pedersen C; Pedersen SS
    Crit Care; 2007; 11(4):R76. PubMed ID: 17625012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y; Yamaguchi T; Kawaguchi T; Tanaka N; Oka H; Nakamura T; Yamagami K; Yoshioka K; Imanishi M
    Respirology; 2012 Feb; 17(2):330-6. PubMed ID: 22059525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia.
    Claessens YE; Mathevon T; Kierzek G; Grabar S; Jegou D; Batard E; Loyer C; Davido A; Hausfater P; Robert H; Lavagna-Perez L; Bernot B; Plaisance P; Leroy C; Renaud B
    Intensive Care Med; 2010 May; 36(5):799-809. PubMed ID: 20232049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever.
    Chirouze C; Schuhmacher H; Rabaud C; Gil H; Khayat N; Estavoyer JM; May T; Hoen B
    Clin Infect Dis; 2002 Jul; 35(2):156-61. PubMed ID: 12087521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic value of serum procalcitonin in identifying the etiology of non-responding community-acquired pneumonia after initial antibiotic therapy].
    Wang Z; Zhang X; Wu J; Zhang W; Kuang H; Li X; Xuan W; Wang K; Ma L
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Nov; 37(11):824-30. PubMed ID: 25604112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin is useful in identifying bacteraemia among children with pneumonia.
    Nascimento-Carvalho CM; Cardoso MR; Barral A; Araújo-Neto CA; Guerin S; Saukkoriipi A; Paldanius M; Vainionpää R; Lebon P; Leinonen M; Ruuskanen O; Gendrel D
    Scand J Infect Dis; 2010 Sep; 42(9):644-9. PubMed ID: 20438288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic and prognostic value of procalcitonin in community-acquired pneumonia.
    Horie M; Ugajin M; Suzuki M; Noguchi S; Tanaka W; Yoshihara H; Kawakami M; Kichikawa Y; Sakamoto Y
    Am J Med Sci; 2012 Jan; 343(1):30-5. PubMed ID: 22207498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin reflects bacteremia and bacterial load in urosepsis syndrome: a prospective observational study.
    van Nieuwkoop C; Bonten TN; van't Wout JW; Kuijper EJ; Groeneveld GH; Becker MJ; Koster T; Wattel-Louis GH; Delfos NM; Ablij HC; Leyten EM; van Dissel JT
    Crit Care; 2010; 14(6):R206. PubMed ID: 21083886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.
    Galetto-Lacour A; Alcoba G; Posfay-Barbe KM; Cevey-Macherel M; Gehri M; Ochs MM; Brookes RH; Siegrist CA; Gervaix A
    Pediatr Infect Dis J; 2013 Nov; 32(11):1175-9. PubMed ID: 23694836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin, a valuable biomarker assisting clinical decision-making in the management of community-acquired pneumonia.
    Lindstrom ST; Wong EK
    Intern Med J; 2014 Apr; 44(4):390-7. PubMed ID: 24528892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of procalcitonin in community-acquired pneumonia.
    Schuetz P; Suter-Widmer I; Chaudri A; Christ-Crain M; Zimmerli W; Mueller B;
    Eur Respir J; 2011 Feb; 37(2):384-92. PubMed ID: 20595156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.